Michael Jernigan
Psychiatric/Mental Health · Smithfield, NCNPI 1356959449
Payments from drug & device makers
Across 268 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Vanda Pharmaceuticals Inc.$647
- Otsuka America Pharmaceutical, Inc.$543
- Supernus Pharmaceuticals, Inc.$347
- Ironshore Pharmaceuticals Inc.$284
- Corium, LLC$264
- plus $837 from 7 others
What the payments were for
- Food & beverage$4,076100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 103 | $1,154 |
| Vanda Pharmaceuticals Inc. | 33 | $647 |
| Otsuka America Pharmaceutical, Inc. | 29 | $543 |
| Supernus Pharmaceuticals, Inc. | 31 | $347 |
| Ironshore Pharmaceuticals Inc. | 14 | $284 |
| Corium, LLC | 12 | $264 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $241 |
| Teva Pharmaceuticals USA, Inc. | 17 | $229 |
| E.r. Squibb & Sons, L.L.C. | 4 | $106 |
| Johnson & Johnson | 4 | $83 |
| Tris Pharma Inc | 3 | $60 |
| Alkermes, Inc. | 3 | $58 |
| Neurocrine Biosciences, Inc. | 3 | $58 |
How this compares
$4,076 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 15 | $891 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $711 |
| Divalproex Sodium | 23 | $568 |
| Haloperidol Decanoate | 12 | $459 |
| Benztropine Mesylate | 20 | $295 |
| Olanzapine | 17 | $226 |
| Bupropion XlBupropion Hcl | 11 | $169 |
| Risperidone | 14 | $152 |
| Hydroxyzine Pamoate | 19 | $100 |
| Trazodone Hcl | 27 | $82 |
| Fluoxetine Hcl | 25 | $58 |
| Sertraline Hcl | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Smithfield
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
- Ronald PattersonFayetteville$25K
- Ajay PatelRaleigh$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.